VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
Presentation to feature complete safety and immunogenicity dataset from the Phase 1 clinical study of VBI-1501 Oral presentation at IDWeek 2018 on Saturday, October 6th, 2018, at 11:10 AM PDT CAMBRIDGE, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines …